Till startsida
To content Read more about how we use cookies on gu.se

Ulrika Stierner


Ulrika Stierner
+46 31-342 1000

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Jubileumsklin, Blå str 2a SU , Göteborg

Department of Oncology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
Visiting Address: Blå stråket 2 SU/Jubileusklin , 413 45 Göteborg

Latest publications

Real-world data on PD-1 inhibitor therapy in metastatic melanoma
A. Arheden, J. Skalenius, Sara Bjursten, Ulrika Stierner, Lars Ny et al.
Acta Oncologica, Journal article 2019
Journal article

Accelerated or conventional whole brain irradiation of malignant melanoma.
Ragnar Hultborn, Johanna Sand, Sara Kinhult, Lotta Lundgren, Ulrika Stierner et al.
Acta oncologica (Stockholm, Sweden), Journal article 2017
Journal article

Melanomincidensen fortsätter att stiga.
Hildur Helgadottir, Ulrika Stierner
Lakartidningen, Magazine article 2017
Magazine article

An approach to suppress the evolution of resistance in BRAF(V600E)-mutant cancer
Y. H. Xue, L. Martelotto, T. Baslan, A. Vides, M. Solomon et al.
Nat Med, Journal article 2017
Journal article

Glycosaminoglycan Profiling in Patients' Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma
Francesco Gatto, N. Volpi, H. Nilsson, Intawat Nookaew, M. Maruzzo et al.
Cell Reports, Journal article 2016
Journal article

Showing 11 - 20 of 60


Trends in cutaneous malignant melanoma in Sweden 1997-2011: Thinner tumours and improved survival among men.
J Lyth, Henry Eriksson, J Hansson, C Ingvar, M Jansson et al.
The British journal of dermatology, Journal article 2015
Journal article


MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma.
Rainer Tuominen, Rosalyn Jewell, Joost J van den Oord, Pascal Wolter, Ulrika Stierner et al.
International journal of cancer. Journal international du cancer, Journal article 2014
Journal article

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group.
T Tandstad, O Ståhl, U Håkansson, O Dahl, H S Haugnes et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Journal article 2014
Journal article

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.
Pia Vihinen, Taina Tervahartiala, Timo Sorsa, Johan Hansson, Lars Bastholt et al.
Cancer immunology, immunotherapy : CII, Journal article 2014
Journal article

Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from sweden.
Hanna Eriksson, Johan Lyth, Eva Månsson-Brahme, Margareta Frohm-Nilsson, Christian Ingvar et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2014
Journal article


Treatment with sorafenib and sunitinib in renal cell cancer: a Swedish register-based study.
Anneli Ambring, Ingela Björholt, Eva Lesén, Ulrika Stierner, Anders Odén
Medical oncology (Northwood, London, England), Journal article 2013
Journal article

Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden.
H Eriksson, J Lyth, E Månsson-Brahme, M Frohm-Nilsson, C Ingvar et al.
European journal of cancer (Oxford, England : 1990), Journal article 2013
Journal article

Showing 11 - 20 of 60

Page Manager: Katarina Olinder Eriksson|Last update: 3/28/2013

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?